![Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer | HTML Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer | HTML](https://www.mdpi.com/cancers/cancers-10-00342/article_deploy/html/images/cancers-10-00342-g004.png)
Cancers | Free Full-Text | Mechanisms Underlying the Action and Synergism of Trastuzumab and Pertuzumab in Targeting HER2-Positive Breast Cancer | HTML
![Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram](https://www.researchgate.net/publication/267932500/figure/fig1/AS:601626331058214@1520450303996/Structure-of-trastuzumab-emtansine-and-mechanisms-of-action-Notes-On-binding-of.png)
Structure of trastuzumab emtansine and mechanisms of action. Notes: On... | Download Scientific Diagram
![Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management](https://www.futuremedicine.com/cms/10.2217/bmt.12.35/asset/images/medium/figure1.gif)
Targeted treatments of HER2-positive metastatic breast cancer: trastuzumab and beyond | Breast Cancer Management
![Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology](https://www.futuremedicine.com/cms/10.2217/fon.13.7/asset/images/medium/figure1.gif)
Trastuzumab emtansine: the first targeted chemotherapy for treatment of breast cancer | Future Oncology
![Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/3939bb25-73dd-487a-8490-1dae0e8d6902/gr1.jpg)
Trastuzumab: mechanism of action, resistance and future perspectives in HER2-overexpressing breast cancer - Annals of Oncology
![SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy](https://minio.scielo.br/documentstore/1678-2690/VmpSNGmgJfQmKMWx9fxmzWP/cb4a5f7022067b7ce664581cd539d9f1d770eb31.png)
SciELO - Brasil - Pertuzumab and trastuzumab: the rationale way to synergy Pertuzumab and trastuzumab: the rationale way to synergy
![Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3621/MediaObjects/13058_2014_3378_Fig1_HTML.jpg)
Trastuzumab emtansine: mechanisms of action and drug resistance | Breast Cancer Research | Full Text
![Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review) Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)](https://www.spandidos-publications.com/article_images/etm/16/3/etm-16-03-2183-g00.jpg)
Novel treatment strategies for patients with HER2‑positive breast cancer who do not benefit from current targeted therapy drugs (Review)
![Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer | British Journal of Cancer Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer | British Journal of Cancer](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41416-019-0635-y/MediaObjects/41416_2019_635_Fig2_HTML.png)
Mechanisms of resistance to trastuzumab emtansine (T-DM1) in HER2-positive breast cancer | British Journal of Cancer
![Resistant mechanism to trastuzumab. (1) Steric effects or masking of... | Download Scientific Diagram Resistant mechanism to trastuzumab. (1) Steric effects or masking of... | Download Scientific Diagram](https://www.researchgate.net/profile/Francois_Claret/publication/227713005/figure/fig3/AS:669654972375048@1536669595214/Resistant-mechanism-to-trastuzumab-1-Steric-effects-or-masking-of-the_Q320.jpg)
Resistant mechanism to trastuzumab. (1) Steric effects or masking of... | Download Scientific Diagram
![Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram](https://www.researchgate.net/profile/Anne-Sophie-Hervent/publication/233829203/figure/fig2/AS:300028787740675@1448543845517/Mode-action-of-current-ErbB2-inhibitors-Trastuzumab-pertuzumab-and-lapatinib-have-a.png)
Mode action of current ErbB2 inhibitors. Trastuzumab, pertuzumab, and... | Download Scientific Diagram
![Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology Figure 2: Mechanism of Action of Trastuzumab and Pathogenesis of its Cardiotoxicity | Radcliffe Cardiology](https://assets.radcliffecardiology.com/s3fs-public/article/2020-12/figure2-mechanism-of-action.png)